
Loading, please wait...

Loading, please wait...

Clinicians often search for reliable biomarkers to predict patient outcomes after invasive vascular procedures. Specifically, recent research suggests that the ABO blood group stroke risk plays a pivotal role in cerebrovascular health. Therefore, a retrospective study involving 316 patients analyzed the association between blood type and complications following carotid angiography and stenting (CAS). Moreover, the findings indicate that patients with non-O blood groups (A, B, or AB) face a significantly higher risk of serious neurological events.
Specifically, the study compared 106 patients with blood group O against 210 patients with non-O blood groups. Additionally, results showed that stroke occurred in 13.8% of patients with non-O blood groups, whereas only 1.9% of those with blood group O were affected. Furthermore, transient ischemic attacks (TIA) were also significantly more frequent in the non-O group. Consequently, this disparity suggests that ABO antigens may serve as natural thrombotic markers. Thus, medical teams should consider adapting their risk assessment strategies based on a patient's blood type.
Why does the ABO blood group stroke risk vary so significantly between individuals? Scientists believe that higher levels of von Willebrand factor (VWF) and Factor VIII in non-O individuals contribute to this prothrombotic state. Specifically, these proteins facilitate platelet adhesion and thrombus formation, which can lead to procedural complications. However, while these results are compelling, practitioners must integrate them with other clinical parameters. Moreover, identifying high-risk patients early allows for better perioperative management and individualized care.
Yes, the study indicates that patients with blood group O have a significantly lower incidence of stroke and TIA following carotid artery stenting compared to those with non-O blood types.
Individuals with blood groups A, B, and AB typically have higher circulating levels of von Willebrand factor and Factor VIII. These factors increase the likelihood of blood clot formation during and after vascular procedures.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Evsen A et al. ABO blood group and cerebrovascular complications after carotid angiography and stenting: a natural thrombotic marker? J Clin Neurosci. 2026 Jun 07. doi: undefined. PMID: 42251813.
Sharma P et al. Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease - PubMed. J Stroke Cerebrovasc Dis. 2023. doi: 10.1016/j.jstrokecerebrovasdis.2023.107215.
Liumbruno GM et al. ABO blood group and thromboembolic diseases. IntechOpen. 2022. doi: 10.5772/intechopen.102123.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study suggests non-O blood groups significantly increase the risk of stroke following carotid artery stenting compared to the O blood group....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today